Hispanic Americans living in the United States and their risk for obesity, diabetes and kidney disease: Genetic and environmental considerations

Postgraduate Medicine

Volumn 127, Issue 5, 2015, Pages 503-510

  Yracheta, Joseph M ^a   Alfonso, Javier ^b   Lanaspa, Miguel A ^b,c   Roncal Jimenez, Carlos ^b,c   Johnson, Sarah B ^b   Sánchez Lozada, Laura G ^c,d   Johnson, Richard J ^b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Colorado Research Partners LLC ^*  (United States)

^d Laboratory of Renal Physiopathology and Department of Nephrology   (Mexico)

Author keywords

Chronic kidney disease; Diabetes; Fructose; Health disparities; Hispanic American; Metabolic syndrome; Obesity; Sugar

Indexed keywords

FRUCTOSE;

BEVERAGE; DIABETES MELLITUS; ENVIRONMENTAL FACTOR; HEREDITY; HISPANIC; HUMAN; INCIDENCE; INSULIN RESISTANCE; KIDNEY DISEASE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; REVIEW; RISK FACTOR; SOCIOECONOMICS; SUGAR INTAKE; CHRONIC KIDNEY FAILURE; EPIDEMIOLOGY; ETHNOLOGY; GENOTYPE ENVIRONMENT INTERACTION; STATISTICS AND NUMERICAL DATA; UNITED STATES;

DIABETES MELLITUS; GENE-ENVIRONMENT INTERACTION; HISPANIC AMERICANS; HUMANS; KIDNEY DISEASES; OBESITY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84964033751     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.1080/00325481.2015.1021234     Document Type: Review

References (107)

1. Available from http://www.census.gov/prod/cen2010/briefs/c2010br-02.pdf.
2. Benabe JE, Rios EV. Kidney disease in the Hispanic population: facing the growing challenge. J Natl Med Assoc 2004;96:789–98.
3. Barbour SJ, Schachter M, Er L, et al. A systematic review of ethnic differences in the rate of renal progression in CKD patients. Nephrol Dial Transplant 2010;25:2422–30.
4. Vivo RP, Krim SR, Cevik C, Witteles RM. Heart failure in Hispanics. J Am Coll Cardiol 2009;53:1167–75.
5. 2013 Annual Data Report; United States Renal Data Systems. 2013.
6. Centers for Disease Control and Prevention. Prevalence of chronic kidney disease and associated risk factors – United States, 1999-2004. MMWR Morb Mortal Wkly Rep 2007;56:161–5.
7. Schneiderman N, Llabre M, Cowie CC, et al. Prevalence of diabetes among Hispanics/Latinos from diverse backgrounds: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Diabetes Care 2014;37:2233–9.
8. Daviglus ML, Talavera GA, Aviles-Santa ML, et al. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA 2012;308:1775–84.
9. Bryc K, Velez C, Karafet T, et al. Colloquium paper: genomewide patterns of population structure and admixture among Hispanic/Latino populations. Proc Natl Acad Sci USA 2010;107:8954–61.
10. CDC Health Disparities and Inequalities Report - United States, 2013. Foreword. MMWR Surveill Summ 2013;62:1–2.
11. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics – 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25–146.
12. Frieden TR. Forward: CDC Health Disparities and Inequalities Report - United States, 2011. MMWR Surveill Summ 2011;60 (Suppl):1–2.
13. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005;28:2745–9.
14. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387–95.
15. Haffner SM, Hazuda HP, Stern MP, et al. Effects of socioeconomic status on hyperglycemia and retinopathy levels in Mexican Americans with NIDDM. Diabetes Care 1989;12:128–34.
16. Dabelea D, Mayer-Davis EJ, Saydah S, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 2014;311:1778–86.
17. Flegal KM, Ezzati TM, Harris MI, et al. Prevalence of diabetes in Mexican Americans, Cubans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey, 1982-1984. Diabetes Care 1991;14:628–38.
18. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305–13.
19. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, et al. Prevalence of hypertension in Hispanic and non-Hispanic white populations. Hypertension 2002;39:203–8.
20. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief 2013:1–8.
21. Richardson SI, Freedman BI, Ellison DH, Rodriguez CJ. Salt sensitivity: a review with a focus on non-Hispanic blacks and Hispanics. J Am Soc Hypertens 2013;7:170–9.
22. Juckett G. Caring for Latino patients. Am Fam Physician 2013;87:48–54.
23. Bertoni B, Budowle B, Sans M, et al. Admixture in Hispanics: distribution of ancestral population contributions in the Continental United States. Hum Biol 2003;75:1–11.
24. Trimble B, Morgenstern LB. Stroke in minorities. Neurol Clin 2008;26:1177–90, xi.
25. Liebson PR. Cardiovascular disease in special populations III: stroke. Prev Cardiol 2010;13:1–7.
26. Ferdinand KC. Hypertension in minority populations. J Clin Hypertens 2006;8:365–8.
27. Liao Y, Cooper RS, Cao G, et al. Mortality from coronary heart disease and cardiovascular disease among adult U.S. Hispanics: findings from the National Health Interview Survey (1986 to 1994). J Am Coll Cardiol 1997;30:1200–5.
28. Sorlie PD, Backlund E, Johnson NJ, Rogot E. Mortality by Hispanic status in the United States. JAMA 1993;270:2464–8.
29. Qi L, Campos H. Genetic predictors for cardiovascular disease in hispanics. Trends Cardiovasc Med 2011;21:15–20.
30. Franzini L, Ribble JC, Keddie AM. Understanding the Hispanic paradox. Ethn Dis 2001;11:496–518.
31. Karter AJ, Ferrara A, Liu JY, et al. Ethnic disparities in diabetic complications in an insured population. JAMA 2002;287:2519–27.
32. Medina-Inojosa J, Jean N, Cortes-Bergoderi M, Lopez-Jimenez F. The Hispanic paradox in cardiovascular disease and total mortality. Prog Cardiovasc Dis 2014;57:286–92.
33. Sievers ML. Disease patterns among southwestern Indians. Public Health Rep 1966;81:1075–83.
34. Howard BV, Lee ET, Cowan LD, et al. Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study. Am J Epidemiol 1995;142:254–68.
35. Howard BV, Lee ET, Yeh JL, et al. Hypertension in adult American Indians. The Strong Heart Study. Hypertension 1996;28:256–64.
36. Sorlie PD, Allison MA, Aviles-Santa ML, et al. Prevalence of hypertension, awareness, treatment, and control in the Hispanic community health study/study of Latinos. Am J Hypertens 2014;27:793–800.
37. Becker BJP. Cardiovascular disease in the Bantu and coloured races of South Africa; hypertensive heart disease. South African Journal of Medical Sciences 1946;11:107–20.
38. Fraser BN. Manifestations and aetiology of hypertension in the Coloured and Bantu. BMJ 1959;1:761–4.
39. Ordman B. A review of the incidence of hypertension in the non-European races; survey of blood pressures in the South African Bantu. Clin Proc 1948;7:183–210.
40. Volkova N, McClellan W, Klein M, et al. Neighborhood poverty and racial differences in ESRD incidence. J Am Soc Nephrol 2008;19:356–64.
41. Fischer MJ, Go AS, Lora CM, et al. CKD in Hispanics: baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC Studies. Am J Kidney Dis 2011;58:214–27.
42. Peralta CA, Shlipak MG, Fan D, et al. Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol 2006;17:2892–9.
43. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000;106:473–81.
44. Pladevall M, Singal B, Williams LK, et al. A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care 2006;29:113–22.
45. Johnson RJ, Stenvinkel P, Martin SL, et al. Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology. Obesity (Silver Spring) 2013;21:659–64.
46. Bremer AA, Mietus-Snyder M, Lustig RH. Toward a unifying hypothesis of metabolic syndrome. Pediatrics 2012;129:557–70.
47. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. 1988. Nutrition 1997;13:65; discussion 4, 6.
48. Golden SH, Brown A, Cauley JA, et al. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors – an Endocrine Society scientific statement. J Clin Endocrinol Metab 2012;97:E1579–639.
49. Kirby JB, Liang L, Chen HJ, Wang Y. Race, place, and obesity: the complex relationships among community racial/ethnic composition, individual race/ethnicity, and obesity in the United States. Am J Public Health 2012;102:1572–8.
50. Wen M, Kowaleski-Jones L. The built environment and risk of obesity in the United States: racial-ethnic disparities. Health Place 2012;18:1314–22.
51. Barnes PM, Adams PF, Powell-Griner E. Health characteristics of the American Indian or Alaska Native adult population: United States, 2004-2008. Natl Health Stat Report 2010;1–22.
52. Rehm CD, Matte TD, Van Wye G, et al. Demographic and behavioral factors associated with daily sugar-sweetened soda consumption in New York City adults. J Urban Health 2008;85:375–85.
53. Ogden CL, Kit BK, Carroll MD, Park S. Consumption of sugar drinks in the United States, 2005-2008. NCHS Data Brief 2011;1–8.
54. Yang Q, Zhang Z, Gregg EW, et al. Added sugar intake and cardiovascular diseases mortality among US adults. JAMA Intern Med 2014;174:516–24.
55. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001;104:2746–53.
56. Thompson FE, McNeel TS, Dowling EC, et al. Interrelationships of added sugars intake, socioeconomic status, and race/ethnicity in adults in the United States: National Health Interview Survey, 2005. J Am Diet Assoc 2009;109:1376–83.
57. Bermudez OI, Tucker KL. Trends in dietary patterns of Latin American populations. Cad Saude Publica 2003;19:S87–99.
58. Emerson H, Larimore LD. Diabetes mellitus: a contribution to its epidemiology based chiefly on mortality statistics. Arch Intern Med 1924;34:585–630.
59. Malik VS, Pan A, Willett WC, Hu FB. Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis. Am J Clin Nutr 2013;98:1084–102.
60. Malik VS, Popkin BM, Bray GA, et al. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010;33:2477–83.
61. Malik VS, Willett WC, Hu FB. Sugar-sweetened beverages and BMI in children and adolescents: reanalyses of a meta-analysis. Am J Clin Nutr 2009;89:438–9; author reply 9-40.
62. Zhang J, Markides KS, Lee DJ. Health status of diabetic Mexican Americans: results from the Hispanic HANES. Ethn Dis 1991;1:273–9.
63. Davis JN, Ventura EE, Weigensberg MJ, et al. The relation of sugar intake to beta cell function in overweight Latino children. Am J Clin Nutr 2005;82:1004–10.
64. Fryar CD, Wright JD, Eberhardt MS, Dye BA. Trends in nutrient intakes and chronic health conditions among Mexican- American adults, a 25-year profile: United States, 1982-2006. Natl Health Stat Report 2012;1–20.
65. Watt TT, Appel L, Roberts K, et al. Sugar, stress, and the Supplemental Nutrition Assistance Program: early childhood obesity risks among a clinic-based sample of low-income Hispanics. J Community Health 2013;38:513–20.
66. de Hoog ML, Kleinman KP, Gillman MW, et al. Racial/ethnic and immigrant differences in early childhood diet quality. Public Health Nutr 2014;17:1308–17.
67. de Oliveira Otto MC, Wu JH, Baylin A, et al. Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc 2013;2:e000506.
68. Ishimoto T, Lanaspa MA, Le MT, et al. Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice. Proc Natl Acad Sci USA 2012;109:4320–5.
69. Lanaspa MA, Ishimoto T, Li N, et al. Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat Commun 2013;4:2434.
70. Ludwig DS. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 2002;287:2414–23.
71. Lanaspa MA, Cicerchi C, Garcia G, et al. Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver. PLoS One 2012;7:e48801.
72. Lanaspa MA, Sanchez-Lozada LG, Choi YJ, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem 2012;287:40732–44.
73. Cicerchi C, Li N, Kratzer J, et al. Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids. FASEB J 2014;28:3339–50.
74. Shapiro A, Mu W, Roncal C, et al. Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am J Physiol Regul Integr Comp Physiol 2008;295: R1370–5.
75. Shapiro A, Tumer N, Gao Y, et al. Prevention and reversal of diet-induced leptin resistance with a sugar-free diet despite high fat content. Br J Nutr 2011;106:390–7.
76. Roncal-Jimenez CA, Lanaspa MA, Rivard CJ, et al. Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake. Metabolism 2011;60:1259–70.
77. Cummings BP, Stanhope KL, Graham JL, et al. Dietary fructose accelerates the development of diabetes in UCD-T2DM rats: amelioration by the antioxidant, alpha-lipoic acid. Am J Physiol Regul Integr Comp Physiol 2010;298:R1343–50.
78. Fowler SP, Puppala S, Arya R, et al. Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study. Hum Genet 2013;132:1059–71.
79. Moreno-Estrada A, Gignoux CR, Fernandez-Lopez JC, et al. Human genetics. The genetics of Mexico recapitulates Native American substructure and affects biomedical traits. Science 2014;344:1280–5.
80. Leon-Mimila P, Villamil-Ramirez H, Villalobos-Comparan M, et al. Contribution of common genetic variants to obesity and obesity-related traits in mexican children and adults. PLoS One 2013;8:e70640.
81. Wing MR, Ziegler JM, Langefeld CD, et al. Analysis of FTO gene variants with obesity and glucose homeostasis measures in the multiethnic Insulin Resistance Atherosclerosis Study cohort. Int J Obes 2011;35:1173–82.
82. Jenkinson CP, Coletta DK, Flechtner-Mors M, et al. Association of genetic variation in ENPP1 with obesity-related phenotypes. Obesity (Silver Spring) 2008;16:1708–13.
83. Moore AF, Jablonski KA, Mason CC, et al. The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program. J Clin Endocrinol Metab 2009;94:449–55.
84. Williams AL, Jacobs SB, Moreno-Macias H, et al. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature 2014;506:97–101.
85. Grimsby JL, Porneala BC, Vassy JL, et al. Race-ethnic differences in the association of genetic loci with HbA1c levels and mortality in U.S. adults: the third National Health and Nutrition Examination Survey (NHANES III). BMC Med Genet 2012;13:30.
86. Davis JN, Le KA, Walker RW, et al. Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption. Am J Clin Nutr 2010;92:1522–7.
87. Thameem F, Igo RP Jr, Freedman BI, et al. A genome-wide search for linkage of estimated glomerular filtration rate (eGFR) in the Family Investigation of Nephropathy and Diabetes (FIND). PLoS One 2013;8:e81888.
88. Kallwitz ER, Daviglus ML, Allison MA, et al. Prevalence of suspected nonalcoholic Fatty liver disease in hispanic/latino individuals differs by heritage. Clin Gastroenterol Hepatol 2015;13:569–76.
89. Palmer ND, Musani SK, Yerges-Armstrong LM, et al. Characterization of European ancestry nonalcoholic fatty liver diseaseassociated variants in individuals of African and Hispanic descent. Hepatology 2013;58:966–75.
90. Heerwagen MJ, Miller MR, Barbour LA, Friedman JE. Maternal obesity and fetal metabolic programming: a fertile epigenetic soil. Am J Physiol Regul Integr Comp Physiol 2010;299:R711–22.
91. Kanaka-Gantenbein C. Fetal origins of adult diabetes. Ann N Y Acad Sci 2010;1205:99–105.
92. Tsai F, Coyle WJ. The microbiome and obesity: is obesity linked to our gut flora? Curr Gastroenterol Rep 2009;11:307–13.
93. Palmer Alves T, Lewis J. Racial differences in chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the United States: a social and economic dilemma. Clin Nephrol 2010;74:S72–7.
94. Rodriguez RA, Hernandez GT, O’Hare AM, et al. Creatinine levels among Mexican Americans, Puerto Ricans, and Cuban Americans in the Hispanic Health and Nutrition Examination Survey. Kidney Int 2004;66:2368–73.
95. Behar DM, Rosset S, Tzur S, et al. African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans. Hum Mol Genet 2010;19:1816–27.
96. Tzur S, Rosset S, Skorecki K, Wasser WG. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease. Nephrol Dial Transplant 2012;27:1498–505.
97. Lora CM, Ricardo AC, Brecklin CS, et al. Recruitment of Hispanics into an observational study of chronic kidney disease: the Hispanic Chronic Renal Insufficiency Cohort Study experience. Contemp Clin Trials 2012;33:1238–44.
98. Kruzel-Davila E, Wasser WG, Aviram S, Skorecki K. APOL1 nephropathy: from gene to mechanisms of kidney injury. Nephrol Dial Transplant 2015. [Epub ahead of print].
99. Shoham DA, Durazo-Arvizu R, Kramer H, et al. Sugary soda consumption and albuminuria: results from the National Health and Nutrition Examination Survey, 1999-2004. PLoS One 2008;3:e3431.
100. Bomback AS, Derebail VK, Shoham DA, et al. Sugar-sweetened soda consumption, hyperuricemia, and kidney disease. Kidney Int 2010;77:609–16.
101. Nakayama T, Kosugi T, Gersch M, et al. Dietary fructose causes tubulointerstitial injury in the normal rat kidney. Am J Physiol Renal Physiol 2010;298:F712–20.
102. Gersch MS, Mu W, Cirillo P, et al. Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am J Physiol Renal Physiol 2007;293:F1256–61.
103. Roncal Jimenez CA, Ishimoto T, Lanaspa MA, et al. Fructokinase activity mediates dehydration-induced renal injury. Kidney Int 2014;86:294–302.
104. Tawatsupa B, Lim LL, Kjellstrom T, et al. Association between occupational heat stress and kidney disease among 37,816 workers in the Thai Cohort Study (TCS). J Epidemiol 2012;22:251–60.
105. Correa-Rotter R, Wesseling C, Johnson RJ. CKD of unknown origin in Central America: the case for a Mesoamerican nephropathy. Am J Kidney Dis 2014;63:506–20.
106. Ziebarth D, Healy-Haney N, Gnadt B, et al. A community-based family intervention program to improve obesity in Hispanic families. WMJ 2012;111:261–6.
107. Johnson RK, Appel LJ, Brands M, et al. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation 2009;120:1011–20.